Ebola Response: DR Congo has started vaccinating frontline health workers against the ongoing Bundibugyo Ebola outbreak in Kisangani (Tshopo), using the Ervebo vaccine under a compassionate-use framework; officials say more than 50,000 doses have arrived, with early priority for health staff and people who had contact with patients, while WHO and Africa CDC stress that there is still no licensed vaccine or treatment specifically for Bundibugyo and clinical trials are underway. Outbreak Pressure: WHO warns the epidemic has reached a “defining moment,” with confirmed cases now above 5,500 and deaths above 2,600, and a major concern that many deaths are happening in communities rather than Ebola treatment centers. Public Health Guidance: WHO has issued updated temporary recommendations for surveillance, case detection, infection control, clinical care, risk communication, and new social measures covering mass gatherings and domestic mobility. Health System Disruption: Kinshasa has suspended academic and para-academic activities in several public higher education institutions in Goma and Bukavu amid the security crisis, affecting registrations and degree-related activities for 2026–2027. Science & Tech Policy: EU4Health/HaDEA signed new contracts to support HERA, including RT-PCR lab kits for Ebola testing capacity in DR Congo and Uganda. Infrastructure & Minerals: Mota-Engil is set to sign a 30-year concession to run the Congolese portion of the Lobito copper-cobalt railway corridor, potentially backed by up to $1 billion in US financing.